CAT and Alzheimer disease: The levels of peroxidation mitigating (normalized CAT, GPX, and GR) mRNAs were elevated in the hippocampus and inferior parietal lobule, but not in the cerebellum of AD patients, which may reflect the protective gene response to the increased peroxidation in the brain regions showing severe AD pathology [49].